CD8A and HIV infectious disease: Overall, these results indicate that ART during the hyperacute phase of HIV infection prevented immune activation of the CD4+ and CD8+ T cell populations, and that initiation of ART during the chronic infection phase reduced immune activation to baseline pre-infection levels.